Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

ALC

Alcon (ALC)

Alcon Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:ALC
DateHeureSourceTitreSymboleSociété
08/05/202422h30Business WireAlcon Announces Results of 2024 Annual General MeetingNYSE:ALCAlcon Inc
01/05/202415h45Business WireAlgoma Central Corporation Reports Financial Results for the 2024 First QuarterNYSE:ALCAlcon Inc
07/04/202423h59Business WireAlcon Publishes Agenda for 2024 Annual General MeetingNYSE:ALCAlcon Inc
12/03/202409h30Business WireAlcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in IndiaNYSE:ALCAlcon Inc
06/03/202415h55Business WireVivity, the World’s Leading EDOF IOL, Reaches One Million MilestoneNYSE:ALCAlcon Inc
06/03/202415h55Business WireVivity, la LIO à profondeur focale accrue première au monde, atteint un million d’implantsNYSE:ALCAlcon Inc
02/03/202400h44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
27/02/202422h30Business WireAlcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023NYSE:ALCAlcon Inc
26/02/202413h00Business WireAlgoma Central Corporation Reports Financial Results for Fiscal 2023NYSE:ALCAlcon Inc
12/02/202422h22Business WireAlgoma Central Corporation to Issue Fiscal 2023 Financial Results on February 26, 2024NYSE:ALCAlcon Inc
01/02/202419h04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ALCAlcon Inc
01/02/202415h02Business WireAlcon Canada lance les lentilles cornéennes TOTAL30 Multifocal pour les patients porteurs de lentilles réutilisables atteints de presbytieNYSE:ALCAlcon Inc
18/01/202414h54Business WireAlgoma Central Corporation continues to grow product tanker business with the acquisition of two additional vesselsNYSE:ALCAlcon Inc
10/01/202410h12Dow Jones NewsAlcon Shares Rise After Dry-Eye Care Drug Shows Promising ResultsNYSE:ALCAlcon Inc
09/01/202423h20Dow Jones NewsAlcon Reports Results for Dry-Eye-Treatment TrialsNYSE:ALCAlcon Inc
09/01/202422h30Business WireAlcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry EyeNYSE:ALCAlcon Inc
05/01/202414h00GlobeNewswire Inc.Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial ArrangementsNYSE:ALCAlcon Inc
27/12/202315h01Business WireAlcon to Present at 2024 Annual J.P. Morgan Healthcare ConferenceNYSE:ALCAlcon Inc
15/11/202317h08Dow Jones NewsAlcon Down Over 5%, On Track for Largest Percent Decrease Since May 2022 -- Data TalkNYSE:ALCAlcon Inc
15/11/202312h11Dow Jones NewsAlcon's Swiss Shares Drop After Guidance Narrowed to Lower End of RangeNYSE:ALCAlcon Inc
14/11/202322h30Business WireAlcon Reports Third Quarter 2023 ResultsNYSE:ALCAlcon Inc
08/11/202315h03Business WireAlcon Canada lance Clareon Vivity, sa plus récente avancée en matière de LIO pour la correction de la presbytieNYSE:ALCAlcon Inc
03/11/202320h00Business WireAlgoma Central Corporation Reports Financial Performance for the 2023 Third QuarterNYSE:ALCAlcon Inc
30/10/202314h01Business WireAlcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023NYSE:ALCAlcon Inc
27/10/202313h00Business WireAlgoma Central Corporation to Issue Third Quarter 2023 Financial Results on November 3, 2023NYSE:ALCAlcon Inc
10/10/202314h01Business WireAlcon Launches TOTAL30 Multifocal Contact Lenses for Patients with PresbyopiaNYSE:ALCAlcon Inc
14/09/202313h00Business WireAlgoma Central Corporation and Furetank Co-Order Two Additional NewbuildsNYSE:ALCAlcon Inc
09/09/202307h01Business WireCataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle DependenceNYSE:ALCAlcon Inc
06/09/202322h30Business WireAlcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical TeamsNYSE:ALCAlcon Inc
15/08/202322h31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:ALCAlcon Inc
 Showing the most relevant articles for your search:NYSE:ALC